Skip to main content
Log in

Formulation development of cream with mupirocin and essential oils for eradication of biofilm mediated antimicrobial resistance

  • Original Paper
  • Published:
Archives of Microbiology Aims and scope Submit manuscript

Abstract

Staphylococcus aureus (S.aureus) is both a colonizer as well as a human pathogen that causes a variety of diseases. Mupirocin is a topical antimicrobial agent which is very effective against S.aureus infection. However, treating the S.aureus infection using mupirocin could be complicated due to biofilm formation. Consequently, resistance to mupirocin occurs and leads to chronic infection. The combination of mupirocin with a compound that has biofilm eradicating effect would be an ideal solution for effectively treating biofilm infections. Therefore, in this study, we have investigated the biofilm inhibitory and eradication effect of mupirocin with three essential oils (Cinnamon Oil (CO), Eugenol (EU) and Eucalyptus Oil (EO)) against sessile S.aureus. From these preliminary results, it was found that the mupirocin-CO (0.2 µg/ml-5.218 mg/ml) combination has a better synergistic antibiofilm effect against sessile S.aureus and the fractional inhibitory concentration index was found to be 0.458. The best combination of mupirocin with CO was loaded into a non-greasy O/W cream. The physico-chemical and microbiological evaluations were carried out for the prepared cream. The prepared cream has better biofilm eradication activity (40%) when compared to a marketed cream (20%).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Archer NK, Mazaitis MJ, Costerton JW, Leid JG, Powers ME, Shirtliff ME (2011) Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence 2(5):445–459

    Article  Google Scholar 

  • Hall-Stoodley L, Costerton JW, Stoodley P (2004) Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2(2):95–108

    Article  CAS  Google Scholar 

  • Hurler J, Sørensen KK, Fallarero A, Vuorela P, Škalko-Basnet N (2013) Liposomes-in-hydrogel delivery system with mupirocin: in vitro antibiofilm studies and in vivo evaluation in mice burn model. Biomed Res Int 2013:1–8

    Article  Google Scholar 

  • Kifer D, Muzinic V, Klaric MS (2016) Antimicrobial potency of single and combined mupirocin and monoterpenes, thymol, menthol and 1, 8-cineole against Staphylococcus aureus planktonic and biofilm growth. J Antibiot 69(9):689–696

    Article  CAS  Google Scholar 

  • Mah TFC, O’Toole GA (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9(1):34–39

    Article  CAS  Google Scholar 

  • Mahalakshmi M, Sankar V (2020) In vıtro antıbacterıal effect of mupırocın ın combınatıon wıth three essentıal oıls agaınst staphylococcus aureus. IJPSR 11(2):705–709

    CAS  Google Scholar 

  • Rafiee-Tehrani M, Mehramizi A (2000) In vitro release studies of piroxicam from oil-in-water creams and hydroalcoholic gel topical formulations. Drug Dev Ind Pharm 26(4):409–414

    Article  CAS  Google Scholar 

  • ReiB S, Pané-Farré J, Fuchs S, François P, Liebeke M, Schrenzel J, Lindequist U, Lalk M, WolzC HM, Engelmann S (2012) Global analysis of the Staphylococcus aureus response to mupirocin. Antimicrob Agents Chemother 56(2):787–804

    Article  Google Scholar 

  • Roy R, Tiwari M, Donelli G, Tiwari V (2018) Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action. Virulence 9(1):522–554

    Article  CAS  Google Scholar 

  • Thomas CM, Hothersall J, Willis CL, Simpson TJ (2010) Resistance to and synthesis of the antibiotic mupirocin. Nat Rev Microbiol 8(4):281–289

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank the Principal, PSG College of Pharmacy and PSG Insitute of Medical Sciences and Research for providing necessary facilities to do the work. We also thank Fourts India, Stedman Pharmaceuticals Pvt Ltd Chennai for providing free gift sample of Mupriocin and Council of Scientific and Industrial Research, New Delhi for providing a major extramural research grant to initiate the preliminary research work (Grant. No: 60(0117)/19/EMR-II). We also acknowledge The Tamil Nadu Dr.M.G.R. Medical University, Chennai, India for providing minor research grant and Dr Sivaram Hariharan for English proofreading and editing.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sankar Veintramuthu.

Ethics declarations

Conflict of interest

The author reports no conflicts of interest. The author alone is responsible for the content and writing of the article.

Additional information

Communicated by Erko Stackebrandt.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sundaramoorthy, M., Karuppaiah, A., Nithyanth, M. et al. Formulation development of cream with mupirocin and essential oils for eradication of biofilm mediated antimicrobial resistance. Arch Microbiol 203, 1707–1715 (2021). https://doi.org/10.1007/s00203-020-02175-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00203-020-02175-5

Keywords

Navigation